Day: January 24, 2022

Sugemalimab with Chemo Demonstrates Improvement in NSCLC Survival Rates

Non-Small-Cell Lung Cancer (NSCLC)
In the year 2020, an estimate of 2.2 million people has been diagnosed with lung cancer. It is the second most commonly diagnosed cancer and is among leading [...]